Renaissance Capital logo

Commentary & News

Swiss rare disease biopharma Relief Therapeutics withdraws $25 million US IPO

RLFT

Relief Therapeutics, a Swiss biopharma commercializing a portfolio of drugs targeting rare diseases, withdrew its plans for an initial public offering on Tuesday. It had filed to raise $25 million by offering 4.2 million units at a price range of $5.50 to $6.50, with each unit consisting of one ADS and one warrant to purchase three-quarters of an ADS, exercisable at 120% of the IPO...read more

Alternative medicine practice Nava Health MD sets proposed price at $6 ahead of $16 million IPO

NAVA

Nava Health MD, which provides alternative and holistic medicine services in clinics and online, revised the terms for its upcoming IPO on Tuesday. The Columbia, MD-based company now plans to raise $16 million by offering 2.7 million shares (51% secondary) at $6. The company had previously filed to offer the same number of shares at a range of $5 to $7. It had originally filed...read more

E-bike maker SONDORS lowers range and changes lead bank ahead of $18 million IPO

SODR

SONDORS, which makes electric bikes and motorcycles, lowered the proposed deal size for its upcoming IPO on Tuesday. In its latest filing, the company also replaced underwriters D.A. Davidson and Lake Street with A.G.P. The Malibu, CA-based company now plans to raise $18 million by offering 2.5 million shares at a price range of $6 to $8. The company had previously filed to offer...read more

Micro-cap financial and tax services provider Lichen China prices downsized US IPO at $4

LICN

Lichen China, which provides financial and tax services in China, raised $16 million by offering 4.0 million shares at $4. The company had planned to sell 4.5 million shares at that price, but lowered its deal size by 11% at the offering. Lichen China listed on the Nasdaq on Monday under the symbol LICN. Univest Securities acted as sole bookrunner on the deal....read more